Cancer treatment

Cancer research

Breakthrough in Personalized Cancer Vaccines: Enhancing Therapeutic Outcomes

Researchers at Beijing University of Chinese Medicine have made significant advancements in developing personalized cancer vaccines, targeting tumor-associated macrophages and enhancing antigen utilization efficiency. This innovative approach has shown promising results in eliciting systemic anti-tumor immunity and alleviating the immunosuppressive tumor microenvironment. Key Takeaways: * The study highlights the challenges in

Cancer diagnosis

Advancing Personalized Cancer Therapy with Nanoparticles

Cancer poses a significant challenge with a high death rate due to its heterogeneity, complexity, and resistance to available treatments. Researchers at Shenzhen University have made recent advancements in using nanoparticles (NPs) to overcome cancer resistance and precision medicines. These NPs exhibit unique physicochemical characteristics, including high surface area-to-volume ratio,

Cancer

Breakthrough in Cancer Therapy: Researchers Develop Tryptophan-Enforced Alg-Iron Oxide Nanoconjugates

Researchers from the Vellore Institute of Technology have made a significant discovery in the field of biomedical engineering, developing tryptophan-enforced alg-iron oxide nanoconjugates that have shown promising results in cancer therapy. According to a recent study published in Biochimica Et Biophysica Acta-general Subjects, these nanoconjugates exhibit excellent thermal stability, superparamagnetic

Cancer diagnosis

Breakthrough in Cancer Treatment: Nanoparticles Improve Ultrasound-Based Therapy

Researchers at Oregon Health & Science University (OHSU) have created a new kind of nanoparticle that enhances the effectiveness and safety of ultrasound-based cancer treatments. This innovative approach combines high-intensity focused ultrasound with powerful chemotherapy drugs, making it more efficient and reducing the risk of cancer recurrence. Key Takeaways: * The

Cancer

Potential Association of the CSMD1 Gene with Moderate Intellectual Disability, Anxiety Disorder, and Obsessive-Compulsive Personality Traits

New research on the CSMD1 gene has shed light on its potential association with moderate intellectual disability, anxiety disorder, and obsessive-compulsive personality traits. According to a study published in the International Journal of Molecular Sciences, the CSMD1 gene plays a crucial role in various biological processes, including complement activity, brain

Cancer

Cancer Survivors Experience Minimal Adverse Events with Cognitive Behavioral Therapy for Insomnia

Research findings indicate that sleep disturbances can be a significant barrier to normal functioning after cancer treatment, and cognitive behavioral therapy for insomnia (CBT-I) has been shown to be effective in addressing these issues. However, few studies have examined the prevalence, severity, and attribution of adverse events (AEs) that occur

Cancer

Breakthrough in Cancer Immunotherapy: Combinatorial Treatment Significantly Improves Tolerability Without Compromising Efficacy

Current research in cancer immunotherapy has revealed promising results in the administration of recombinant interleukin 2 (IL-2) fusion proteins. However, these treatments are often hindered by dose-limiting toxicities, including vascular leak syndrome. To address this issue, researchers from the University of Zurich have explored the therapeutic potential of co-administering signaling

Cancer research

Advances in Immunotherapy for HPV-Related Genital Tract Cancers

Researchers at the University of Illinois have presented fresh data on oncology - genital tract cancer, revealing that human papillomavirus (HPV)-related lower genital cancers pose a significant health burden, with approximately 45,000 new cases diagnosed annually. Current effective treatment modalities include chemoradiotherapy, systemic chemotherapy, and immune checkpoint inhibitors

Cancer research

Breakthrough in Cancer Gene Therapy: Micellar Formulation Demonstrates Potent and Tolerable Treatment for Anti-cancer Immunotherapy

Researchers at the Technical University of Denmark (DTU) have made a significant discovery in cancer gene therapy, developing a micellar formulation that provides potent and tolerable treatment for anti-cancer immunotherapy. The study, published in The Journal of Immunology, demonstrates the effectiveness of using micellar formulation to deliver TLR7 agonists, a

Cancer research

Epstein-Barr Virus Plays Key Role in Cancer Gene Therapy, Research Reveals

Recent research published in Guangxi Yike Daxue xuebao has shed new light on the role of Epstein-Barr virus (EBV) in cancer gene therapy. According to a study conducted by scientists at Sun Yat-sen University Cancer Center, EBV's lytic genes play a significant role in tumorigenesis, challenging the current

Cancer research

Breakthrough in Cancer Gene Therapy: Star-Shaped Copolypeptide-Mediated Transfection of 3D Organoids

Scientists at National Cheng Kung University in Tainan, Taiwan, have made a groundbreaking discovery in the field of cancer gene therapy. A new study published in the European Polymer Journal reveals the development of star-shaped block copolypeptides as novel gene carriers capable of directly transfecting entire cell clusters within three-dimensional

Cancer research

KAHR Announces Positive Results for DSP107 in Combination with Atezolizumab in Metastatic Colorectal Cancer Patients

KAHR, a clinical-stage biotech company, announced positive results for the Phase 2 dose expansion cohort of DSP107, a first-in-class bi-specific 4-1BB T-cell engager, in combination with atezolizumab, an anti-PD-L1 cancer immunotherapy, in patients with 3rd line microsatellite stable metastatic colorectal cancer (MSS-CRC). The combination demonstrated anti-tumor activity and extended survival,